Host: |
Mouse |
Applications: |
FC |
Reactivity: |
Human |
Note: |
FOR SCIENTIFIC EDUCATIONAL RESEARCH USE ONLY (RUO). MUST NOT BE USED IN DIAGNOSTIC OR OTHER MEDICAL APPLICATIONS. |
Short Description: |
Mouse monoclonal antibody anti-Complement receptor type 1 is suitable for use in Flow Cytometry research applications. |
Clonality: |
Monoclonal |
Clone ID: |
E11 |
Conjugation: |
PE |
Isotype: |
IgG1k |
Formulation: |
PBS with 0.05% Proclin300, 1% BSA |
Storage Instruction: |
Recommend storing between 2-8°C and protecting from prolonged exposure to light. Do not freeze this product. |
Tissue Specificity | Present on erythrocytes, a subset of T cells, mature B cells, follicular dendritic cells, monocytes and granulocytes. |
Function | Membrane immune adherence receptor that plays a critical role in the capture and clearance of complement-opsonized pathogens by erythrocytes and monocytes/macrophages. Mediates the binding by these cells of particles and immune complexes that have activated complement to eliminate them from the circulation. Acts also in the inhibition of spontaneous complement activation by impairing the formation and function of the alternative and classical pathway C3/C5 convertases, and by serving as a cofactor for the cleavage by factor I of C3b to iC3b, C3c and C3d,g, and of C4b to C4c and C4d. Also plays a role in immune regulation by contributing, upon ligand binding, to the generation of regulatory T cells from activated helper T cells. (Microbial infection) Acts as a receptor for Epstein-Barr virus. |
Protein Name | Complement Receptor Type 1C3b/C4b ReceptorCd Antigen Cd35 |
Database Links | Reactome: R-HSA-6798695Reactome: R-HSA-8877330Reactome: R-HSA-977606 |
Cellular Localisation | MembraneSingle-Pass Type I Membrane Protein |
Alternative Antibody Names | Anti-Complement Receptor Type 1 antibodyAnti-C3b/C4b Receptor antibodyAnti-Cd Antigen Cd35 antibodyAnti-CR1 antibodyAnti-C3BR antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance